No Detail Found!

Effect of Exenatide Therapy on Platelet Function in Type 2 Diabetes Mellitus

Author(s)
Murat Çalapkulu Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital,Ankara,Turkey
Muhammed Erkam Sencar Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital,Ankara,Turkey
Ilknur Ozturk Unsal Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital,Ankara,Turkey
Davut Sakiz Department of Endocrinology and Metabolism, Mardin State Hospital,Mardin,Turkey
Mustafa Ozbek Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital,Ankara,Turkey
Erman Cakal Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital,Ankara,Turkey
Abstract
Objective: The purpose of the present study was to determine the e ects of exenatide treatment on platelet function in type 2 diabetes mellitus (DM) patients. Study Design: Case-control observational study. Place and Duration of Study: University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara from October 2016 to October 2018. Methodology: This study included 50 patients with type 2 DM, who had started exenatide therapy; and age-gender matched 54 control subjects. The biochemical data and BMI of the patients were analysed at the time of admission and after six months of exenatide treatment. Results: PDW (platelet distribution width) and MPV (mean platelet volume) were higher in the diabetic patient group than in the control group (p <0.01 and p=0.036, respectively). Signi cant positive correlations were determined between PDW and BMI (p<0.001), FPG (p <0.001), and HbA1c (p<0.001). After six months of exenatide treatment, PDW (p = 0.015) values and platelet count (p = 0.003) were signi cantly decreased. Conclusions: Exenatide causes a decrease in PDW value and platelet count independent of its positive e ect on lipid pro le, glycemic regulation, and weight loss, which contributes to explain the e ect of treatment on the cardiovascular system through a di erent mechanism.
Publication Details
Page(s) 1035-1039
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 9, Year: 2021

Request the full text from PASTIC

Keywords
type 2 diabetes mellitus, Platelet count, Mean Platelet Volume, Platelet Distribution Width, Exenatide
0

Citations

0

Downloads

93

Views